Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Kintara Therapeutics, Inc. (DMPI)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Assets |
| Cash and equivalents | 3.0 | 4.9 | 7.1 | 11.8 | 8.8 | 14.1 | 19.3 | 10.5 |
| Other current assets | 3.0 | 4.3 | 1.1 | 1.5 | 1.3 | 0.9 | 0.8 | 1.3 |
| Total current assets | 6.0 | 9.2 | 8.2 | 13.3 | 10.1 | 15.0 | 20.1 | 11.8 |
| Property, plant, and equipment, net | 0.7 | 0.7 | 0.8 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 |
| Total assets | 6.7 | 9.9 | 13.2 | 15.9 | 12.8 | 17.7 | 22.3 | 13.5 |
| |
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other current liabilities | 2.8 | 3.2 | 3.5 | 4.0 | 3.2 | 3.4 | 3.0 | 2.8 |
| Total current liabilities | 2.8 | 3.2 | 3.5 | 4.0 | 3.2 | 3.4 | 3.0 | 2.8 |
| Other liabilities | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Total liabilities | 3.0 | 3.3 | 3.6 | 4.2 | 3.4 | 3.6 | 3.2 | 3.0 |
| |
| Shareholders' equity [+] | 3.8 | 6.6 | 9.6 | 11.8 | 9.4 | 14.1 | 19.2 | 10.6 |
| Paid-in capital | 141.2 | 140.6 | 138.3 | 135.5 | 127.7 | 126.8 | 125.1 | 106.8 |
| Retained earnings | -148.0 | -144.8 | -141.3 | -136.4 | -130.9 | -125.6 | -119.7 | -111.2 |
| Tangible shareholders' equity | 3.8 | 6.6 | 9.6 | 11.8 | 9.4 | 14.1 | 19.2 | 10.6 |
|